ArticleCancer immunology, immunotherapy : CII2026

Dual targeting of CD155 augments the antitumor efficacy of ROR1-CAR-T cells in ovarian cancer.

Yingjun Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.